BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8307121)

  • 1. Vitamin E prevents the place learning deficit and the cholinergic hypofunction induced by AF64A.
    Wörtwein G; Stackman RW; Walsh TJ
    Exp Neurol; 1994 Jan; 125(1):15-21. PubMed ID: 8307121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglioside AGF2 promotes task-specific recovery and attenuates the cholinergic hypofunction induced by AF64A.
    Emerich DF; Walsh TJ
    Brain Res; 1990 Sep; 527(2):299-307. PubMed ID: 2253037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AF64A (ethylcholine mustard aziridinium) impairs acquisition and performance of a spatial, but not a cued water maze task: relation to cholinergic hypofunction.
    Opello KD; Stackman RW; Ackerman S; Walsh TJ
    Physiol Behav; 1993 Dec; 54(6):1227-33. PubMed ID: 7507594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and neuroanatomical consequences of a unilateral intraventricular infusion of AF64A and limitations on the neuroprotective effects of nimodipine.
    Maier DL; Isaacson RL
    Brain Res; 1994 Jun; 648(2):281-90. PubMed ID: 7922542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct profile of working memory errors following acute or chronic disruption of the cholinergic septohippocampal pathway.
    Stackman RW; Walsh TJ
    Neurobiol Learn Mem; 1995 Nov; 64(3):226-36. PubMed ID: 8564376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemicholinium-3 prevents the working memory impairments and the cholinergic hypofunction induced by ethylcholine aziridinium ion (AF64A).
    Chrobak JJ; Spates MJ; Stackman RW; Walsh TJ
    Brain Res; 1989 Dec; 504(2):269-75. PubMed ID: 2598029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cortical cholinergic hypofunction and memory retention deficits through intracortical AF64A infusions.
    Mouton PR; Meyer EM; Dunn AJ; Millard W; Arendash GW
    Brain Res; 1988 Mar; 444(1):104-18. PubMed ID: 3359282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation of fetal cholinergic neurons into the hippocampus attenuates the cognitive and neurochemical deficits induced by AF64A.
    Emerich DF; Black BA; Kesslak JP; Cotman CW; Walsh TJ
    Brain Res Bull; 1992 Feb; 28(2):219-26. PubMed ID: 1596741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of repeated administration of (-)-nicotine on AF64A-induced learning and memory impairment in rats.
    Hiramatsu M; Yamatsu T; Kameyama T; Nabeshima T
    J Neural Transm (Vienna); 2002 Mar; 109(3):361-75. PubMed ID: 11956957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AF64A-induced working memory impairment: behavioral, neurochemical and histological correlates.
    Chrobak JJ; Hanin I; Schmechel DE; Walsh TJ
    Brain Res; 1988 Oct; 463(1):107-17. PubMed ID: 3196899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of spatial working memory of rats in radial maze performance induced by ethylcholine mustard aziridinium picrylsulfonate (AF64A-P): retention curve analysis.
    Inagawa K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Feb; 14(1):9-17. PubMed ID: 8048282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of WEB 1881 FU on AF64A (ethylcholine aziridinium ion)-induced impairment of hippocampal cholinergic neurons and learning acquisition.
    Hashimoto M; Hashimoto T; Kuriyama K
    Eur J Pharmacol; 1991 Dec; 209(1-2):9-14. PubMed ID: 1814764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.
    Vickroy TW; Watson M; Leventer SM; Roeske WR; Hanin I; Yamamura HI
    J Pharmacol Exp Ther; 1985 Dec; 235(3):577-82. PubMed ID: 3841155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo.
    Fisher A; Mantione CR; Abraham DJ; Hanin I
    J Pharmacol Exp Ther; 1982 Jul; 222(1):140-5. PubMed ID: 6896342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of physostigmine on AF64A-induced impairment of learning acquisition in rats.
    Ogura H; Yamanishi Y; Yamatsu K
    Jpn J Pharmacol; 1987 Aug; 44(4):498-501. PubMed ID: 3682413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficits in cholinergic neurotransmission markers induced by ethylcholine mustard aziridinium (AF64A) in the rat hippocampus: sensitivity to treatment with the monoamine oxidase-B inhibitor L-deprenyl.
    Ricci A; Mancini M; Strocchi P; Bongrani S; Bronzetti E
    Drugs Exp Clin Res; 1992; 18(5):163-71. PubMed ID: 1490432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose- and delay-dependent working/episodic memory impairments following intraventricular administration of ethylcholine aziridinium ion (AF64A).
    Chrobak JJ; Walsh TJ
    Behav Neural Biol; 1991 Sep; 56(2):200-12. PubMed ID: 1759941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AF64A (ethylcholine aziridinium ion), a cholinergic neurotoxin, selectively impairs working memory in a multiple component T-maze task.
    Chrobak JJ; Hanin I; Walsh TJ
    Brain Res; 1987 Jun; 414(1):15-21. PubMed ID: 3620916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Learning deficits after unilateral AF64A lesions in the rat basal forebrain: role of cholinergic and noncholinergic systems.
    Nakamura S; Tani Y; Maezono Y; Ishihara T; Ohno T
    Pharmacol Biochem Behav; 1992 May; 42(1):119-30. PubMed ID: 1528935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term exposure to high levels of corticosterone aggravates AF64A-induced cholinergic hypofunction in rat hippocampus in vivo.
    Amoroso D; Kindel G; Wülfert E; Hanin I
    Brain Res; 1994 Oct; 661(1-2):9-18. PubMed ID: 7530584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.